CD4 and myeloid sarcoma: The activation of CLR signaling activates APCs, enabling the differentiation of CD4+ IL-17-producing effector T cells (TH17 cells) during host defense against fungal infection and pathogenesis of autoimmune diseases such as MS and EAE15–18.